NEUROCRINE BIOSCIENCES
RegisteredCombined Mark
Never miss important updates for NEUROCRINE BIOSCIENCES
Get instant alerts when status changes, similar marks are filed, or renewal deadlines approach
Ownership
NB
Owner Name
Type: Organization / Corporation
Address
Address not available
Critical Dates
First Use Date
Dec 31, 2024
Filing Date
Aug 16, 2021
Registration Date
Mar 31, 2026
Mark Descriptions
Goods
Class 5
Pharmaceutical preparations for human use for treatment of Huntington's Disease, chorea associated with Huntington's Disease, schizophrenia, adjunctive treatment of schizophrenia, cognitive impairment associated with schizophrenia, epilepsy, epileptic encephalopathy with continuous spike-and-wave during sleep, SCN8A-related epilepsy with encephalopathy...
Services
Class 42
Pharmaceutical preparations for human use for treatment of Huntington's Disease, chorea associated with Huntington's Disease, schizophrenia, adjunctive treatment of schizophrenia, cognitive impairment associated with schizophrenia, epilepsy, epileptic encephalopathy with continuous spike-and-wave during sleep, SCN8A-related epilepsy with encephalopathy...
Mark Elements
Text Mark
NEUROCRINE BIOSCIENCES
Category
Trademark
Standard Characters
No
Color Claim
Yes
Color Details
The color(s) pink, gray and aqua blue is/are claimed as a feature of the mark.
Design Search Codes
260126
Trademark Timeline
Filing Date
Publication Date
First Use
Registration Date
USPTO Records
No documents found for this trademark.